Literature DB >> 3003207

Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983.

R A Strikas, L J Anderson, R A Parker.   

Abstract

Surveillance data on nonpolio enterovirus (NPEV) from the Centers for Disease Control (Atlanta, Georgia) for the United States from 1970 to 1983 were analyzed for the temporal and geographic patterns of the most common types of NPEV isolated. The number of isolates varied from year to year, partly because of variation in the number of reporting laboratories and partly because of true variation in the rate of isolation. The most common types isolated also varied from year to year, yet the 15 most common types over the entire 14-year period accounted for 65%-89% of isolates for a given year. The 15 most common types of NPEV had two basic patterns of isolation, one in which a type had periodic epidemic years and the other in which it did not. In 11 of the 14 years there was one or more epidemic types, each accounting for greater than or equal to 20% of all isolates of NPEV that year. The six most common isolates in March, April, and May predicted an average of 59% of the total isolates detected in July-December of that year.

Mesh:

Year:  1986        PMID: 3003207     DOI: 10.1093/infdis/153.2.346

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  66 in total

1.  Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.

Authors:  M S Oberste; K Maher; M L Kennett; J J Campbell; M S Carpenter; D Schnurr; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR.

Authors:  Monique Nijhuis; Noortje van Maarseveen; Rob Schuurman; Sandra Verkuijlen; Machiel de Vos; Karin Hendriksen; Anton M van Loon
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses.

Authors:  M Steven Oberste; Silvia Peñaranda; Mark A Pallansch
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 4.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

5.  Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach.

Authors:  François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

Review 6.  Nucleic acid detection systems for enteroviruses.

Authors:  H A Rotbart
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

7.  Analysis of the genetic and the corresponding antigenic variability of the VP1 3' end of ECHO virus type 11 and ECHO virus type 30.

Authors:  Lamjed Bouslama; Jawhar Gharbi; Mahjoub Aouni
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

8.  Transient broca aphasia in an elderly man caused by coxsackievirus B5.

Authors:  Anne-Sophie Endres; Thomas Helms; Simone Steinführer; Helga Meisel
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

9.  Multicenter beta trial of the GeneXpert enterovirus assay.

Authors:  Christine B Kost; Beverly Rogers; M Steven Oberste; Christine Robinson; Brenda L Eaves; Kristi Leos; Susan Danielson; Malini Satya; Fred Weir; Frederick S Nolte
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

10.  In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.

Authors:  M G Woods; G D Diana; M C Rogge; M J Otto; F J Dutko; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.